Nurx and Journey Clinical founders raise $6M for AI mental health startup Siggy
What's the deal? SiggyDealroom has a profile for this one. Try Dealroom →, a New York-based mental health startup, has raised $6 million in pre-seed funding led by Village Global. The service uses AI to collect patient histories and track progress between appointments with licensed clinicians.
Who's behind it? Siggy was founded by Jonathan Sabbagh and Edvard Engeseth, who began building the company in late 2025. Sabbagh co-founded psychedelic therapy provider Journey Clinical, while Engeseth co-founded telehealth company Nurx, which he says scaled to more than 2 million patients and over $100 million in annual revenue run rate before its 2022 merger with Thirty MadisonDealroom has a profile for this one. Try Dealroom →.
Who else is backing it? The round — Siggy's first outside funding — also drew Albert Wenger of Union Square Ventures, MercuryDealroom has a profile for this one. Try Dealroom → co-founder Immad Akhund, Toyin Ajayi through Coalition OperatorsDealroom has a profile for this one. Try Dealroom →, PsyMed VenturesDealroom has a profile for this one. Try Dealroom →, Mystic VenturesDealroom has a profile for this one. Try Dealroom →, and Gokul Rajaram.
How it works: A free AI conversation collects a patient's history before a video appointment with a licensed clinician. Patients can then connect devices such as WhoopDealroom has a profile for this one. Try Dealroom →, Oura, and Apple Watch, with self-reported and wearable data generating a daily "Siggy Score" visible to both patients and clinicians.
What's the endgame? The founders say the service aims to improve coordination between therapists and prescribing clinicians, a gap they argue limits treatment. If a patient's score shifts, the software flags it for clinical review, though clinicians keep responsibility for diagnoses, prescriptions, and medication decisions.
Why now? Siggy will use the capital to hire clinicians and engineers, build its software, and meet regulatory requirements. It is already taking paying patients before a wider launch and plans to test the service further with those users.
Access strategy: Siggy accepts commercial insurance in all 50 US states, is expanding into government programs, and will keep the service permanently free for veterans. It does not prescribe controlled substances and is not a crisis service.
The signal: The raise fits a 2026 shift toward AI embedded in clinician-led mental health care, rather than standalone wellness chatbots. Comparable rounds — Blossom Health's $20 million and Jimini Health's $17 million — show investor appetite for the model, but Siggy's significance will depend on whether it can prove clinical value and sustain an insured service.
Read more: tradersunion.com
Image credit: Generated with Gemini
